Biomedical applications of organometal-peptide conjugates

43Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Peptides are well suited as targeting vectors for the directed delivery of metal-based drugs or probes for biomedical investigations. This chapter describes synthetic strategies for the preparation of conjugates of medically interesting peptides with covalently bound metal complexes. Peptides that were used include neuropeptides (enkephalin, neuropeptide Y, neurotensin), uptake peptides (TAT and poly-Arg), and intracellular localization sequences. To these peptides, a whole variety of transition metal complexes has been attached in recent years by solid-phase peptide synthesis (SPPS) techniques. The metal complex can be attached to the peptide on the resin as part of the SPPS scheme. Alternatively, the metal complex may be attached to the peptide as a postsynthetic modification. Advantages as well as disadvantages for either strategy are discussed. Biomedical applications include radiopharmaceutical applications, anticancer and antibacterial activity, metal-peptide conjugates as targeted CO-releasing molecules, and metal-peptide conjugates in biosensor applications. © 2010 Springer-Verlag Berlin Heidelberg.

Cite

CITATION STYLE

APA

Metzler-Nolte, N. (2010). Biomedical applications of organometal-peptide conjugates. Topics in Organometallic Chemistry, 32, 195–217. https://doi.org/10.1007/978-3-642-13185-1_8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free